{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Shida D"],"funding":["Japan Agency for Medical Research and Development","National Cancer Research and Development Funds"],"pagination":["3352-3363"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10394152"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["114(8)"],"pubmed_abstract":["Large-scale genomic sequencing of colorectal cancers has been reported mainly for Western populations. Differences by stage and ethnicity in the genomic landscape and their prognostic impact remain poorly understood. We investigated 534 Japanese stage III colorectal cancer samples from the Phase III trial, JCOG0910. Targeted-capture sequencing of 171 potentially colorectal cancer-associated genes was performed, and somatic single-nucleotide variants and insertion-deletions were determined. Hypermutated tumors were defined as tumors with MSIsensor score >7 and ultra-mutated tumors with POLE mutations. Genes with alterations associated with relapse-free survival were analyzed using multivariable Cox regression models. In all patients (184 right-sided, 350 left-sided), mutation frequencies we"],"journal":["Cancer science"],"pubmed_title":["Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910."],"pmcid":["PMC10394152"],"funding_grant_id":["29-A-3","17km0405106h0005","26-A-3"],"pubmed_authors":["Shimada Y","Tonooka T","Yamasaki S","Ojima H","Murakami Y","Kobatake T","Shida D","Masaki T","Kazama S","Ito M","Uetake H","Shiozawa M","Takii Y","Okamura S","Shibata T","Hamaguchi T","Takeyama H","Kuchiba A","Kanato K","Kanemitsu Y"],"additional_accession":[]},"is_claimable":false,"name":"Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910.","description":"Large-scale genomic sequencing of colorectal cancers has been reported mainly for Western populations. Differences by stage and ethnicity in the genomic landscape and their prognostic impact remain poorly understood. We investigated 534 Japanese stage III colorectal cancer samples from the Phase III trial, JCOG0910. Targeted-capture sequencing of 171 potentially colorectal cancer-associated genes was performed, and somatic single-nucleotide variants and insertion-deletions were determined. Hypermutated tumors were defined as tumors with MSIsensor score >7 and ultra-mutated tumors with POLE mutations. Genes with alterations associated with relapse-free survival were analyzed using multivariable Cox regression models. In all patients (184 right-sided, 350 left-sided), mutation frequencies we","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Aug","modification":"2025-04-20T03:17:07.1Z","creation":"2025-04-20T03:17:07.1Z"},"accession":"S-EPMC10394152","cross_references":{"pubmed":["37189003"],"doi":["10.1111/cas.15834"]}}